Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
회사 코드HBIO
회사 이름Harvard Bioscience Inc
상장일Oct 21, 2013
설립일2000
CEOMr. James W. (Jim) Green
직원 수330
유형Ordinary Share
회계 연도 종료Oct 21
주소84 October Hill Rd
도시HOLLISTON
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호01746-1371
전화15088938999
웹사이트https://www.harvardbioscience.com/
회사 코드HBIO
상장일Oct 21, 2013
설립일2000
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음